Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -10.17% is in line with its 5-year average of -9.31%, around the middle of its 5-year range (-98.84%–63.70%).
45.78% below its 12-month average of -6.98%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2020 (2020-12-31): 6.02%.
EBITDA MARGIN
-10.17%
EBITDA MARGIN AVG TTM
-6.98%
EBITDA MARGIN AVG 3Y
-8.14%
EBITDA MARGIN AVG 5Y
-9.31%
EBITDA MARGIN AVG 10Y
-8.68%
EBITDA MARGIN AVG 15Y
-15.57%
EBITDA MARGIN AVG 20Y
-15.19%
CURRENT VS TTM AVG
-45.78%
CURRENT VS 3Y AVG
-25.01%
CURRENT VS 5Y AVG
-9.24%
CURRENT VS 10Y AVG
-17.21%
CURRENT VS 15Y AVG
+34.68%
CURRENT VS 20Y AVG
+33.04%
Enveric Biosciences, Inc.
Market Cap
$6.49M
EBITDA Margin
-10.17%
TTM Avg
-6.98%
3Y Avg
-8.14%
5Y Avg
-9.31%
Market Cap
$6.57M
EBITDA Margin
-485.73%
TTM Avg
-485.73%
3Y Avg
-485.73%
5Y Avg
-485.73%
Market Cap
$6.80M
EBITDA Margin
-9012.26%
TTM Avg
-10323.55%
3Y Avg
-8965.35%
5Y Avg
-8208.29%
Market Cap
$6.21M
EBITDA Margin
-110.02%
TTM Avg
-99.60%
3Y Avg
-109.65%
5Y Avg
-93.07%
Market Cap
$6.82M
EBITDA Margin
-430.70%
TTM Avg
-678.73%
3Y Avg
-962.21%
5Y Avg
-5357.45%
Market Cap
$6.13M
EBITDA Margin
-729.87%
TTM Avg
-884.05%
3Y Avg
-981.20%
5Y Avg
-851.95%
Market Cap
$6.08M
EBITDA Margin
-417.17%
TTM Avg
-417.17%
3Y Avg
-417.17%
5Y Avg
-417.17%
Market Cap
$5.98M
EBITDA Margin
-41051.94%
TTM Avg
-32118.88%
3Y Avg
-145781.05%
5Y Avg
-130042.11%
Market Cap
$7.07M
EBITDA Margin
-4847.72%
TTM Avg
-2918.14%
3Y Avg
-1630.06%
5Y Avg
-1069.46%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | $6.49M | -10.17% | -6.98% | -8.14% | -9.31% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.57M | -485.73% | -485.73% | -485.73% | -485.73% |
| Aclarion, Inc. (ACON)vs › | $6.80M | -9012.26% | -10323.55% | -8965.35% | -8208.29% |
| Biomerica, Inc. (BMRA)vs › | $6.21M | -110.02% | -99.60% | -109.65% | -93.07% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.82M | -430.70% | -678.73% | -962.21% | -5357.45% |
| Femasys Inc. (FEMY)vs › | $6.13M | -729.87% | -884.05% | -981.20% | -851.95% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.08M | -417.17% | -417.17% | -417.17% | -417.17% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.98M | -41051.94% | -32118.88% | -145781.05% | -130042.11% |
| Co-Diagnostics, Inc. (CODX)vs › | $7.07M | -4847.72% | -2918.14% | -1630.06% | -1069.46% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.17M | 3.56% | 3.56% | 3.56% | 3.56% |
Gross Margin
0.0%
EBITDA Margin
-10.2%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2020-12-31 | 6.02% |
| 2020-09-30 | -6.63% |
| 2020-06-30 | -7.91% |
| 2020-03-31 | -10.86% |
| 2019-12-31 | -15.50% |
| 2019-09-30 | -10.96% |
| 2019-06-30 | -8.30% |
| 2019-03-31 | -6.90% |
| 2018-12-31 | -98.84% |
| 2018-09-30 | 63.70% |
| 2018-06-30 | -1.22% |
| 2018-03-31 | -4.94% |
| 2017-12-31 | -26.20% |
| 2017-09-30 | -24.97% |
| 2017-06-30 | -21.87% |
| 2017-03-31 | 0.47% |
| 2016-12-31 | -12.36% |
| 2016-09-30 | -7.78% |
| 2016-06-30 | -12.49% |
| 2016-03-31 | -12.40% |
| 2015-09-30 | -1.29% |
| 2015-06-30 | 12.54% |
| 2007-12-31 | -58.56% |
| 2007-09-30 | -196.72% |
| 2007-06-30 | 42.31% |
| 2007-03-31 | 65.86% |
| 2006-12-31 | -69.02% |
| 2006-09-30 | -76.16% |
| 2006-06-30 | -54.25% |
| 2006-03-31 | -163.77% |
| 2005-12-31 | -112.02% |
| 2005-09-30 | 16.01% |
| 2005-06-30 | 15.87% |
| 2005-03-31 | 7.71% |
| 2004-12-31 | 35.44% |
| 2004-09-30 | -30.80% |
| 2004-06-30 | -42.61% |
| 2004-03-31 | -61.54% |
| 2003-12-31 | -24.25% |
| 2003-09-30 | -24.56% |
| 2003-06-30 | -74.99% |
| 2003-03-31 | -13.63% |
| 2002-12-31 | 3.06% |
| 2002-09-30 | 6.39% |
